期刊文献+

骨髓增生异常综合征的细胞凋亡分子机制(综述) 被引量:1

Progress in the study of abnormal molecular mechanism of myelodysplastic syndromes (A review)
下载PDF
导出
摘要 骨髓增生异常综合征的基本病理特征是骨髓的无效造血。骨髓造血细胞的凋亡增加是导致无效造血的主要原因之一。目前认为 ,骨髓基质细胞分泌的细胞因子如肿瘤坏死因子 (TNF -α)、转化生长因子 β(TGF - β) ,Fas受体 /配体的高表达 ,凋亡调节基因的异常 ,如促凋亡基因 (Bax、Bad)与抗凋亡基因 (Bcl- 2、Bcl-X)的比值增高 ,及半胱氨酸 /天冬氨酸特异的蛋白酶 (caspases)的过度激活等 ,与病人的骨髓造血细胞凋亡增加有关。 Myelodysplastic syndromes are a group of clonal diseases pathologically characterized by ineffective hematopoiesis which is thought to be mainly due to abnormal apoptosis of hematopoietic cells. It is generally assumed that overexpression of some cytokines of stromal cells secrete (such as tumor necrosis factor α(TNF-α), transforming growth factor β(TGF-β), Fas receptor and Fas ligand), abnormality of apoptosis-regulating genes, (for instance, the ratio of pro-apoptotic genes such as Bax versus anti-apoptotic genes such as Bcl-2 increases), overactivation of cystein aspartate specific proteases (caspases) are correlated closely with increased apoptosis of patients' hematopoietic cells.
出处 《暨南大学学报(自然科学与医学版)》 CAS CSCD 2002年第4期24-28,共5页 Journal of Jinan University(Natural Science & Medicine Edition)
关键词 骨髓增生异常综合征 细胞凋亡 E2F1基因 myelodysplastic syndrome programmed cell death E2F1
  • 相关文献

参考文献22

  • 1[1]PARKER J E, MUFTI J. Ineffective haemopoiesis and apoptosis in myelodysplastic syndromes[J]. Br J Hematol, 1998, 101(2): 220-230.
  • 2[2]MICHAELA F-R, DIDIER B, MARTINE G, et al. Ineffective erythropoiesis in myelodysplastic syndromes: correlation with Fas expression but not with lack of erythropoietin receptor signal transduction[J]. Br J Hematol, 1999, 106(2): 464-473.
  • 3[3]SINGHAL S, POWLES R, TRELEAVEN J, et al. Cytomegaloviremia after autografting for leukemia: clinical significance and lack of effect on engraftment[J]. Leukemia, 1997, 11(6): 835-838.
  • 4[4]GUPTA P, NIEHANS G A, LEROY S C, et al. Fas ligand expression in the bone marrow in myelodysplastic syndromes correlates with FAB subtype and anemia, and predicts survival [J]. Leukemia, 1999, 13(1): 44-53.
  • 5[5]MUNDLE S D, MATIVI B Y, BAGAI K, et al. Spontaneous down-regulation of Fas associated phosphatase-1 may contribute to excessive apoptosis in myelodysplastic marrows[J]. Int J Hematol, 1999, 70(2): 83-90.
  • 6[6]HELLSTROM-LINDBERG E, SCHMIDT-MENDE J, FORSBLOM A M, et al. Apoptosis in refractory anaemia with ringed sideroblasts is initiated at the stem cell level and associated with increased activation of caspases[J]. Br J Hematol, 2001, 112(3): 714-726.
  • 7[7]BOUDARD D, SORDET O, VASSELON C, et al. Expression and activity of caspases 1 and 3 in myelodysplastic syndromes[J]. Leukemia,2000, 14(12): 2045-2051.
  • 8[8]BOUSCARY D, YAN L C, MARTINE G, et al. Activity of the caspase-3/CPP32 enzyme is increased in early stage myelodysplastic syndromes with excessive apoptosis, but caspase inhibition does not enhance colony formation in vitro[J]. Experi Hematol, 2000, 28(7): 784-791.
  • 9[9]ALI A, MUNDLE S D, RAGASA D, et al. Sequential activation of caspase-1 and caspase-3-like proteases during apoptosis in myelodsplastic syndromes[J]. J Hematotherapy & Stem Cell Research, 1999, 8(4): 343-356.
  • 10[10]KATSUHIRO M, LEILA A, YUICHI M. Fusarenon-X induced apoptosis in HL-60 cells depends on caspase activation and cytochrome C release[J]. Toxicology, 2002, 172(2): 103-112.

同被引文献8

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部